Afternoon Briefing: AI Infrastructure Boom Clashes With Geopolitical Risk as Copper Demand Surges

Citizens of Stonkistan, we convene at a crossroads between technological acceleration and geopolitical friction. The market's dominant narrative today crystallizes around an unglamorous but consequential asset: copper. Bloomberg reports that as AI demand for electricity surges across US data centers and power grids, copper has become the critical input chokepoint—yet domestic production has stagnated for decades. This structural constraint matters because it reveals the gap between the AI boom's promise and the physical infrastructure reality. Data centers don't run on optimism; they run on electrons delivered through copper wiring. The bulls have bid technology stocks higher on AI proliferation, but the supply chain whispers a different story. This tension will intensify as earnings season advances through Tesla, Intel, and IBM this week.

Geopolitically, the Strait of Hormuz situation has shifted from simmering to active risk. Bloomberg reports Iran reversed its decision to reopen the waterway and fired on vessels attempting passage, creating a near-standstill in shipping traffic. This is not noise. Approximately 21% of global petroleum passes through Hormuz; any sustained disruption ripples through energy costs, shipping margins, and risk premiums across equities. Energy stocks are "on fire," as one headline notes, but the question is whether that fire reflects genuine fundamental strength or flight-to-safety positioning ahead of potential geopolitical escalation. Watch oil prices and shipping volatility closely this week—they're leading indicators of where institutional money anticipates risk.

The crypto attention radar is flashing but essentially unreliable. ASTEROID and other low-liquidity tokens spiking 1,018% and 677% on near-zero volume signals pure noise—retail gambling in the shadows. What's notable is that despite these eye-watering percentage moves, they command minimal price discovery and near-total absence of institutional engagement. The legitimate signals come from AAVE's elevated news coverage alongside price movement, suggesting genuine protocol-level discussions are occurring beneath the retail chatter. Crypto remains a secondary market, but it's a useful barometer of risk appetite when viewed through the lens of relative volatility.

The Hims and Hers story warrants serious attention. A telehealth platform compounding and undercutting Novo Nordisk's Ozempic pricing presents either genuine disruptive economics or a regulatory enforcement event waiting to materialize. The FDA's position on pharmacy compounding of GLP-1 agonists remains ambiguous, creating binary tail risk. This exemplifies a broader theme: regulatory clarity is collapsing across multiple sectors, from AI governance (Chamath's critique of "crying wolf" hype) to pharmaceutical distribution channels. Uncertainty premium is rising.

Blue Origin's successful booster reuse and Berkshire's leadership transition under Greg Abel represent long-cycle capital allocation shifts—less immediate price-moving, more structurally significant. These stories confirm that patient capital is repositioning for infrastructure, energy, and aerospace exposure as geopolitical risk premiums persist.

Today's character is volatile and bifurcated: speculative froth in crypto and low-cap names contrasts sharply with structural uncertainty in energy, semiconductors, and geopolitics. The market is pricing contradictions—bullish on AI growth, nervous about supply chains and Middle East stability. This is the comportment of intelligence without conviction.

This address is market commentary. Not financial advice.